TY - JOUR
T1 - Automated ventricular mapping with multi-atlas fluid image alignment reveals genetic effects in Alzheimer's disease
AU - Chou, Yi Yu
AU - Leporé, Natasha
AU - de Zubicaray, Greig I.
AU - Carmichael, Owen T.
AU - Becker, James T.
AU - Toga, Arthur W.
AU - Thompson, Paul M.
N1 - Funding Information:
This work was funded by grants from the National Institute for Biomedical Imaging and Bioengineering, the National Center for Research Resources, and the National Institute on Aging (EB01651, RR019771, AG016570 to PT). Additional support was provided by NCRR Resource grant P41 RR13642 to AWT, and by the National Institute on Aging (AG021431 to JTB). The authors are grateful to Stephen Rose at the University of Queensland Center for Magnetic Resonance for his work acquiring the MRI scan data.
PY - 2008/4/1
Y1 - 2008/4/1
N2 - We developed and validated a new method to create automated 3D parametric surface models of the lateral ventricles in brain MRI scans, providing an efficient approach to monitor degenerative disease in clinical studies and drug trials. First, we used a set of parameterized surfaces to represent the ventricles in four subjects' manually labeled brain MRI scans (atlases). We fluidly registered each atlas and mesh model to MRIs from 17 Alzheimer's disease (AD) patients and 13 age- and gender-matched healthy elderly control subjects, and 18 asymptomatic ApoE4-carriers and 18 age- and gender-matched non-carriers. We examined genotyped healthy subjects with the goal of detecting subtle effects of a gene that confers heightened risk for Alzheimer's disease. We averaged the meshes extracted for each 3D MR data set, and combined the automated segmentations with a radial mapping approach to localize ventricular shape differences in patients. Validation experiments comparing automated and expert manual segmentations showed that (1) the Hausdorff labeling error rapidly decreased, and (2) the power to detect disease- and gene-related alterations improved, as the number of atlases, N, was increased from 1 to 9. In surface-based statistical maps, we detected more widespread and intense anatomical deficits as we increased the number of atlases. We formulated a statistical stopping criterion to determine the optimal number of atlases to use. Healthy ApoE4-carriers and those with AD showed local ventricular abnormalities. This high-throughput method for morphometric studies further motivates the combination of genetic and neuroimaging strategies in predicting AD progression and treatment response.
AB - We developed and validated a new method to create automated 3D parametric surface models of the lateral ventricles in brain MRI scans, providing an efficient approach to monitor degenerative disease in clinical studies and drug trials. First, we used a set of parameterized surfaces to represent the ventricles in four subjects' manually labeled brain MRI scans (atlases). We fluidly registered each atlas and mesh model to MRIs from 17 Alzheimer's disease (AD) patients and 13 age- and gender-matched healthy elderly control subjects, and 18 asymptomatic ApoE4-carriers and 18 age- and gender-matched non-carriers. We examined genotyped healthy subjects with the goal of detecting subtle effects of a gene that confers heightened risk for Alzheimer's disease. We averaged the meshes extracted for each 3D MR data set, and combined the automated segmentations with a radial mapping approach to localize ventricular shape differences in patients. Validation experiments comparing automated and expert manual segmentations showed that (1) the Hausdorff labeling error rapidly decreased, and (2) the power to detect disease- and gene-related alterations improved, as the number of atlases, N, was increased from 1 to 9. In surface-based statistical maps, we detected more widespread and intense anatomical deficits as we increased the number of atlases. We formulated a statistical stopping criterion to determine the optimal number of atlases to use. Healthy ApoE4-carriers and those with AD showed local ventricular abnormalities. This high-throughput method for morphometric studies further motivates the combination of genetic and neuroimaging strategies in predicting AD progression and treatment response.
UR - http://www.scopus.com/inward/record.url?scp=40649126317&partnerID=8YFLogxK
U2 - 10.1016/j.neuroimage.2007.11.047
DO - 10.1016/j.neuroimage.2007.11.047
M3 - Article
C2 - 18222096
AN - SCOPUS:40649126317
SN - 1053-8119
VL - 40
SP - 615
EP - 630
JO - NeuroImage
JF - NeuroImage
IS - 2
ER -